These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2164651)

  • 1. "Poor prognosis" metastatic gestational trophoblastic disease: the prognostic significance of the scoring system in predicting chemotherapy failures.
    Mortakis AE; Braga CA
    Obstet Gynecol; 1990 Aug; 76(2):272-7. PubMed ID: 2164651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in "poor prognosis" metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study.
    Curry SL; Blessing JA; DiSaia PJ; Soper JT; Twiggs LB
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):357-62. PubMed ID: 2536911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy.
    Lurain JR; Brewer JI
    Obstet Gynecol; 1985 Jun; 65(6):830-6. PubMed ID: 2987766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver metastases of gestational trophoblastic tumor.
    Bakri YN; Subhi J; Amer M; Ezzat A; Sinner W; Tweijry A; Jabbar FA
    Gynecol Oncol; 1993 Jan; 48(1):110-3. PubMed ID: 8380786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk metastatic gestational trophoblastic tumors. Current management.
    Lurain JR
    J Reprod Med; 1994 Mar; 39(3):217-22. PubMed ID: 7518518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission rates and significance of prognostic factors in gestational trophoblastic tumors.
    Ayhan A; Yapar EG; Deren O; Kişnişçi H
    J Reprod Med; 1992 May; 37(5):461-5. PubMed ID: 1324312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of high-risk gestational trophoblastic disease.
    Lurain JR
    J Reprod Med; 1998 Jan; 43(1):44-52. PubMed ID: 9475149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk metastatic gestational trophoblastic disease.
    Gordon AN; Gershenson DM; Copeland LJ; Saul PB; Kavanagh JJ; Edwards CL
    Obstet Gynecol; 1985 Apr; 65(4):550-6. PubMed ID: 2580255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
    Homesley HD
    J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
    Lurain JR; Singh DK; Schink JC
    J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophosphamide-vincristine for high-risk gestational trophoblastic disease.
    Soper JT; Evans AC; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
    Obstet Gynecol; 1994 Jan; 83(1):113-7. PubMed ID: 8272290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and prognosis of post term choriocarcinoma in The Netherlands.
    Lok CA; Ansink AC; Grootfaam D; van der Velden J; Verheijen RH; ten Kate-Booij MJ
    Gynecol Oncol; 2006 Nov; 103(2):698-702. PubMed ID: 16790263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of patients with trophoblastic tumors in the Academic Medical Center: 31 patients in 10 years, 1983-1992].
    Laan R; Bakker P; Lammes FB
    Ned Tijdschr Geneeskd; 1995 Sep; 139(36):1829-34. PubMed ID: 7477506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors.
    Matsui H; Suzuka K; Iitsuka Y; Seki K; Sekiya S
    Gynecol Oncol; 2000 Jul; 78(1):28-31. PubMed ID: 10873405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of brain metastases in patients with high-risk gestational trophoblastic tumors.
    Newlands ES; Holden L; Seckl MJ; McNeish I; Strickland S; Rustin GJ
    J Reprod Med; 2002 Jun; 47(6):465-71. PubMed ID: 12092015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy-resistant gestational trophoblastic neoplasia treated successfully with cisplatin, etoposide, and bleomycin.
    Willemse PH; Aalders JG; Bouma J; Sleijfer DT
    Obstet Gynecol; 1988 Mar; 71(3 Pt 2):438-40. PubMed ID: 2450325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease.
    Dobson LS; Lorigan PC; Coleman RE; Hancock BW
    Br J Cancer; 2000 May; 82(9):1547-52. PubMed ID: 10789722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic gestational trophoblastic disease: experience at the New England Trophoblastic Disease Center, 1965 to 1985.
    DuBeshter B; Berkowitz RS; Goldstein DP; Cramer DW; Bernstein MR
    Obstet Gynecol; 1987 Mar; 69(3 Pt 1):390-5. PubMed ID: 3029641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
    Lurain JR; Nejad B
    Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary.
    Fülöp V; Szigetvári I; Szepesi J; Végh G; Bátorfi J; Nagymányoki Z; Török M; Berkowitz RS
    J Reprod Med; 2010; 55(5-6):253-7. PubMed ID: 20626182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.